Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BLOOD & BIOLOGICS.


11487W

Newton Labs, Conyers, GA, Feb. 20 (Atlanta). FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 stated that the firm's Bio-Protect, labeled as assisting "with elimination of biological toxins and to help with symptoms such as high fever, flu-like symptoms and vomiting vomiting, ejection of food and other matter from the stomach through the mouth, often preceded by nausea. The process is initiated by stimulation of the vomiting center of the brain by nerve impulses from the gastrointestinal tract or other part of the body. ," was not the subject of an approved biologics license, rendering the product misbranded mis·brand  
tr.v. mis·brand·ed, mis·brand·ing, mis·brands
To brand or label misleadingly or fraudulently.

Adj. 1.
. The agency also cited Newton's Web site via a bioterrorism link. The letter did not refer to any GMP GMP (guanosine monophosphate): see guanine.  violations in connection with investigator Myla Chapman's Nov. 29 and Dec. 6, 2001, inspection.
COPYRIGHT 2002 Washington Information Source, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Warning Letter Bulletin
Date:Mar 25, 2002
Words:81
Previous Article:CDRH PROMO UNTITLED LETTERS.
Next Article:FOODS/DIETARY SUPPLEMENTS.



Related Articles
Blood/Biologics.
Medical devices.
Numerous cleaning validation issues uncovered in Bayer biologics audit.
Mercy Blood Bank cited for software validation, error reporting.
Blood and tissue center lacks quality, maintenance controls.
Quality control failures result in 483, warning letter for blood bank.
Blood bank nets 8-item 483 for quality control failures.
Animal drugs/feed.
GMP violations for blood bank lack of validation data.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles